Project Details
Description
This study will explore the potential utility of 2 novel biomarkers of VTE, sPSeland GPVI alone on in combination with D dimer to improve the accuracy for the diagnosis ofacute VTE. Results of this study will also be used to inform clinicians and researchers aboutthe expected levels of these markers over time in patients treated with direct factor Xainhibitors. This data will be useful in useful in the assessment of patients with suspectedrecurrent VTE who are currently being treated with these agents.
Status | Active |
---|---|
Effective start/end date | 17/04/25 → 16/04/26 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.